I am a nuclear medicine physician who has extensive experience and broad expertise in therapeutic and diagnostic applications of nuclear medicine in oncology.
My past clinical and research experience has been multifaceted, and includes combining the therapeutic and diagnostic components of nuclear medicine, which is referred to as theranostics. From the therapeutic perspective, my special expertise is in the development of peptide receptor radionuclide therapy (PRRT) of gut and lung neuroendocrine tumors, including special investigational and molecular translational analyses to facilitate their diagnosis and therapy. In addition, I have substantial experience with radioiodine therapy of differentiated thyroid cancer and hyperthyroidism. I also have expertise in the utilization of systemic radioimmunotherapy for loco-regional disease, brain tumors, ovarian carcinoma, and non-Hodgkin lymphoma.
In the diagnostic arena my expertise includes a broad range of diagnostic endocrine applications in nuclear medicine such as receptor scintigraphy, 68Ga-octreotide PET/TC, 18FDG-PET/CT in oncology, radio-immuno-scintigraphy, and sentinel node scintigraphy.
I am the author or co-author of more than 100 peer-reviewed publications, and serve on the editorial boards of several scientific journals including the Journal of Nuclear Medicine and the European Journal of Nuclear Medicine and Molecular Imaging.

IAEA Events attended:

• IVICT-2019